The Board of Directors of Hangzhou Alltest Biotech Co., Ltd. has authorized a buyback plan on July 22, 2022.
Hangzhou Alltest Biotech Co., Ltd.
Equities
688606
CNE1000053G6
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
47.74 CNY | -0.29% |
|
-6.37% | -30.41% |
04-29 | China, HK stocks rise, led by property shares | RE |
04-26 | Hangzhou Alltest Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-30.41% | 510M | |
-12.05% | 7.33B | |
+0.90% | 5.35B | |
+32.11% | 5.68B | |
-18.56% | 3.71B | |
+5.52% | 2.49B | |
-64.99% | 2.35B | |
-11.40% | 2.22B | |
+28.84% | 2.23B | |
-15.91% | 1.61B |
- Stock Market
- Equities
- 688606 Stock
- News Hangzhou Alltest Biotech Co., Ltd.
- Hangzhou Alltest Biotech Co., Ltd. authorizes a Buyback Plan.